No Data
Express News | Winner Medical: The company sells multiple products in offline chain supermarkets such as Pang Donglai and Yonghui Superstores.
GF SEC: The WeChat Mini Store is testing a gift function, which is expected to bring new growth to the textile and apparel Industry.
The WeChat ecosystem has been continuously improving in recent years. Bullish on WeChat Mini Stores, which are expected to break through by giving gifts, achieving rapid growth in the e-commerce Business. Online revenue has already become one of the important income sources in the Clothing and Home Textiles Industry.
Winner Medical (300888): All Cotton Era's sustainable development provides new opportunities for medical overseas expansion.
The differentiated positioning of the Cotton Era may achieve sustainable growth. Despite the pressure on the market environment, the Cotton Era has performed well this year, which should be attributed to the company's long-term accumulation and three core advantages: the cotton concept, quality genes, and medical background. "The cotton concept"
Research Reports Gold Mining丨Guosen: Maintain Winner Medical "Outperform the Market" rating, raising the Target Price to 43-47 yuan.
Guosen's Research Reports indicate that in the fourth quarter of 2024, Winner Medical (300888.SZ) is expected to achieve accelerated growth in its Consumer Business against the backdrop of intensified marketing efforts and the fermentation of industry hotspots. Third-party online data shows that in October-November 2024, the combined sales growth rate of the Cotton Times brand and Nice Princess brand has significantly accelerated compared to the first three quarters of 2024, with sales growth for the company's two core categories, cotton soft towels and sanitary napkins, exceeding 30% in October-November. In the Medical Sector, the high baseline impact from epidemic prevention products that began in the third quarter has basically been eliminated, returning to normalized growth. In terms of external growth, acquisitions are underway.
Winner Medical (300888): Material marketing combined with Industry events highlights product advantages, and the Business segment is expected to accelerate growth.
Subject: Company Update: In the fourth quarter of 2024, the company's Consumer Business is expected to achieve accelerated growth against the backdrop of enhanced marketing efforts and the fermentation of hot events in the Industry. Third-party online data shows that in October-November 2024, all...
Research Reports on Investment Opportunities | HTSC: Initiates "Buy" rating for Winner Medical, driven by Consumer and healthcare dual engines.
HTSC's Research Reports indicate that Winner Medical (300888.SZ) is a health enterprise positioned for dual drivers of "Consumer + Medical," with an upward operational turning point. The initial coverage gives a "Buy" rating with a Target Price of 48.44 yuan. Looking ahead: 1) The Consumer sector adheres to a product-leading Global Strategy, integrating marketing for precise deployment, with Operations gradually improving. Both online and offline, as well as non-woven/non-woven fully engaged, growth in 2024 continues to accelerate, with bullish growth potential in the Consumer sector. 2) In the Medical sector, infection protection products are sufficiently digesting a high base, returning to normalized growth in Q3; regular product growth is accelerating, with both internal and external efforts expected to drive results.
